Latest Breaking News On - Influential small molecule - Page 1 : comparemela.com

SUZHOU, China, March 31, 2023 /PRNewswire/ Kintor Pharmaceutical Limited (Kintor Pharma, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced business highlights and financial results for the year ended 31 December 2022. Business Highlights Dr. Youzhi Tong, founder, Chairman, and CEO of Kintor Pharma, commented, 2022 has been a challenging year for.

Hong kongJianzhong zhangKintor pharmaPrnewswire kintor pharmaceutical limited pharmaMeeting of chinese hair research societyUniversity people hospitalHong kong stock exchangeInnovative pharmaceutical companiesRapid progress on global clinical developmentHong kong listed companiesKintor pharmaceuticalInnovation companiesPharmaceutical limitedShanghai hong kong stock connectYouzhi tongGlobal clinical development